Covered recipient · General Payments record
ANUPAMA NUTAKKI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2022
$1,141.43
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $144.80 | 9 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $44.32 | 3 |
| Astellas Pharma US Inc | $18.71 | 1 |
| Xeris Pharmaceuticals, Inc. | $18.26 | 1 |
| DEXCOM, INC. | $17.42 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.23 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.38 | 1 |
| Amgen Inc. | $13.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $13.48 | 03/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939236543 | CMS |
| Astellas Pharma US Inc | $18.71 | 01/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 940104591 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $17.23 | 03/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929933915 | CMS |
| Dexcom, Inc. | $17.42 | 12/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 957306427 | CMS |
| Novo Nordisk Inc | $14.44 | 01/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899285437 | CMS |
| Novo Nordisk Inc | $13.96 | 03/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899245669 | CMS |
| Novo Nordisk Inc | $15.92 | 04/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898764919 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.38 | 07/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 959518001 | CMS |
| Xeris Pharmaceuticals, Inc. | $18.26 | 04/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 946470237 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.